A double-masked comparison of betaxolol and levobunolol for the treatment of primly open-angle glaucoma.

SUMMARY

This article shows a double masked study between Betaxolol 0.5% drops and Levobunolol 0.5% drops involving 40 glaucomatous patients.

20 randomized patients were given Betaxolol. And other 20 patients were given Levobunolol in a randomized way as well.

This work developed over a period of 12 weeks during which time the effects of the above mentioned drugs on the ocular were observed specially over the Intraocular Pressure as well as their possible systemic effects.

RESUMO

Este artigo mostra os resultados de um estudo duplo-cego entre betaxolol solução oftálmica a 0,5% e levobunolol solução oftálmica a 0,5% em 40 pacientes glaucomatoses.

Vinte (20) pacientes, ao acaso, receberam betaxolol e outros vinte (20) pacientes foram, aleatoriamente, selecionados para o tratamento com levobunolol.

O trabalho desenvolveu-se durante 12 semanas, nas quais os efeitos drogas mencionadas foram obervados, especialmente sobre a pressão intra-ocular, bem como seus possíveis efeitos sistêmicos.

Full text available only in PDF format.

ACKNOWLEDGEMENT

Edgar Mario Wagner Statistics Professor Faculdade de Medicina da Universidade Federal do Rio Grande do Sul

BIBLIOGRAPHY

• ¹
  Berrospi, A.R., Leibowite, H. W.: Betaxolol: A new - adrenergic blocking agent for the treatment of glaucoma. Arch. Ophthalm. 1982, 100: 943-946.
• ²
  Allen, R. C.: Betaxolol in the treatment of glaucoma, multiclinic trials. Ophthalmology 91 (supp.): 142, 1984.
• ³
  Schoene, R. B., Abulan, T., Ward, R. L. et al.: Effects topical betaxolol, timolol and placebo on pulmonary function in asthamatic bronchitis. Am. J. Ophthalmology. 1984, 97/86-92.
• ⁴
  Van Buskirk, E. M., Fraufelder, F. T.: Ocular beta-blockers and systemic effects Am. J. Ophthalmology. 1984. 98: 623-624.
• ⁵
  Dunn. T. L. Gerber, M. J., A.S., Fernandez, E., Iseman, M. D., Cherniak, R. M.: Timolol-induced brochospam, utility of betaxolol as an alternative ocular hypotensive agent in patients with asthma. Clin. Res. 33: 20A, 1985.
• ⁶
  Atkins, J. M., Puch, B. R., Timewell, R. M. Cardiovascular effects of topical beta blockers during exercise. Am. J. Ophthalmology. 99: 173-175. 1975.
• ⁷
  Caldwell Dr., Salisbury C. R., Guzek, J. P.: Effects of topical betaxolol in ocular hypertensive patients. Arch. Ophthalmology 102: 539, 1984.
• ⁸
  Radius R. L.: Use of betaxolol in the reduction of elevated intraocular pressure. Arch. Ophthalmology. 101: 898, 1983.
• ⁹
  Levy, N. S., Boone, L.: Effect of 0,25% betaxolol vs placebo. Glaucoma 5: 230, 1983.
• ¹⁰
  Allen, R. C., Epstein, D. L.: Double-masked trial of betaxolol timolol in glaucoma patients. Invest. Ophthalmol. Vis Sci, (suppl) 22: 40, 1982.
• ¹¹
  Berry, D. P., Van Buskirk, E. M., Shilds, M. B.: Betaxolol and timolol. A comparison of efficacy and side effects. Arch. Ophthal. 102: 42, 1984.
• ¹²
  Vukich, J. A., Leef, D. L., Allen, R. C.: Betaxolol in Patients with coexistent chronic open-angle glaucoma and pulmonary disease. Invest. Opht. Vis Sci (Suppl) 26: 227, 1985.
• ¹³
  Smith, J. P., weeks RH, Newland. E. F., et al.: Betaxolol and acetazolamide: Combined hypotensive effect. Arch. Ophthal. 102: 1794, 1984.
• ¹⁴
  Thomas, J. V., Epstein, D. L.: Timolol and epinephrine in primary open-angle glaucoma. Arch. Ophthal. 99: 91-95, 1981.
• ¹⁵
  Cyrlin M. N.. Thomas, J. V., Epstein, D. L.: Additive effect of epinephrine to Timolol therapy in primary open-angle glaucoma. Arch. Ophthalmology. 100: 414-418, 1982.
• ¹⁶
  Hernandez, H., Cervantes, R., Frati, A., Hurtado, R., McDonalds, T. O.: Cardiovascular and effects of topical glaucoma therapies in normal subjects. Journal Toxicol. Cut. Ocular Toxicol. 2: 99-106, 1983.

Publication Dates

• Publication in this collection
  Jan-Feb 1990